These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antimicrobial peptides: Sustainable application informed by evolutionary constraints. Chen X; Han J; Cai X; Wang S Biotechnol Adv; 2022 Nov; 60():108012. PubMed ID: 35752270 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections. Zhu Y; Hao W; Wang X; Ouyang J; Deng X; Yu H; Wang Y Med Res Rev; 2022 Jul; 42(4):1377-1422. PubMed ID: 34984699 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial peptides for combating drug-resistant bacterial infections. Xuan J; Feng W; Wang J; Wang R; Zhang B; Bo L; Chen ZS; Yang H; Sun L Drug Resist Updat; 2023 May; 68():100954. PubMed ID: 36905712 [TBL] [Abstract][Full Text] [Related]
6. Challenges and advances in antimicrobial peptide development. Botelho Sampaio de Oliveira K; Lopes Leite M; Albuquerque Cunha V; Brito da Cunha N; Luiz Franco O Drug Discov Today; 2023 Aug; 28(8):103629. PubMed ID: 37230283 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections. Askari P; Yousefi M; Foadoddini M; Neshani A; Aganj M; Lotfi N; Movaqar A; Ghazvini K; Namaei MH Curr Microbiol; 2022 Feb; 79(4):102. PubMed ID: 35152319 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial Peptides: the Achilles' Heel of Antibiotic Resistance? Lewies A; Du Plessis LH; Wentzel JF Probiotics Antimicrob Proteins; 2019 Jun; 11(2):370-381. PubMed ID: 30229514 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial peptides: features, applications and the potential use against covid-19. Mabrouk DM Mol Biol Rep; 2022 Oct; 49(10):10039-10050. PubMed ID: 35606604 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria. Moravej H; Moravej Z; Yazdanparast M; Heiat M; Mirhosseini A; Moosazadeh Moghaddam M; Mirnejad R Microb Drug Resist; 2018; 24(6):747-767. PubMed ID: 29957118 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial peptides - Unleashing their therapeutic potential using nanotechnology. Gera S; Kankuri E; Kogermann K Pharmacol Ther; 2022 Apr; 232():107990. PubMed ID: 34592202 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial peptides: Opportunities and challenges in overcoming resistance. Bucataru C; Ciobanasu C Microbiol Res; 2024 Sep; 286():127822. PubMed ID: 38986182 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Peptides Therapy: An Emerging Alternative for Treating Drug-Resistant Bacteria. Mba IE; Nweze EI Yale J Biol Med; 2022 Dec; 95(4):445-463. PubMed ID: 36568838 [TBL] [Abstract][Full Text] [Related]
15. Exploring the arsenal of antimicrobial peptides: Mechanisms, diversity, and applications. Savitskaya A; Masso-Silva J; Haddaoui I; Enany S Biochimie; 2023 Nov; 214(Pt B):216-227. PubMed ID: 37499896 [TBL] [Abstract][Full Text] [Related]
17. No country for old antibiotics! Antimicrobial peptides (AMPs) as next-generation treatment for skin and soft tissue infection. Răileanu M; Borlan R; Campu A; Janosi L; Turcu I; Focsan M; Bacalum M Int J Pharm; 2023 Jul; 642():123169. PubMed ID: 37356506 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Peptide Exposure Selects for Resistant and Fit Stenotrophomonas maltophilia Mutants That Show Cross-Resistance to Antibiotics. Blanco P; Hjort K; Martínez JL; Andersson DI mSphere; 2020 Sep; 5(5):. PubMed ID: 32999081 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in the design of antimicrobial peptide conjugates. Silva ARP; Guimarães MS; Rabelo J; Belén LH; Perecin CJ; Farías JG; Santos JHPM; Rangel-Yagui CO J Mater Chem B; 2022 May; 10(19):3587-3600. PubMed ID: 35262120 [TBL] [Abstract][Full Text] [Related]